Clinuvel Pharmaceuticals Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Clinuvel Pharmaceuticals Limited with three other
companies in this sector in the United States:
Crispr Therapeutics AG
sales of $5.16 million
Ascendis Pharma A/S
of which 100%
During the year ended June of 2016, sales at
Clinuvel Pharmaceuticals Limited were $5.11 million.
increase of 68.5%
versus 2015, when the company's sales were $3.03 million.